The stability of pharmaceutical compounds is a critical aspect of drug development and manufacturing. For Strontium Ranelate (CAS 135459-90-4), understanding its degradation pathways is essential for ensuring its efficacy and safety throughout its shelf-life. As a dedicated supplier, we invest in detailed studies to elucidate these pathways.

Our research utilizes advanced analytical techniques, including LC-MS (Liquid Chromatography-Mass Spectrometry), to identify and characterize the degradation products of Strontium Ranelate under various stress conditions. These conditions, such as exposure to heat, light, humidity, and oxidative or hydrolytic environments, are designed to accelerate any potential breakdown processes.

Through LC-MS analysis, we can precisely determine the molecular weight and structural fragments of the degradation products. This information allows us to propose probable structures and understand the chemical reactions that lead to their formation. For Strontium Ranelate, studies have indicated moderate susceptibility to hydrolytic, oxidative, and thermal degradation, while it shows resistance to photolytic breakdown.

The insights gained from these degradation pathway studies are invaluable. They inform our manufacturing processes to minimize the formation of unwanted byproducts and guide the development of appropriate packaging and storage recommendations for our clients. By providing this detailed knowledge when you buy Strontium Ranelate, we empower you to maintain the highest standards of quality and stability in your own formulations.

As a trusted manufacturer and supplier, our commitment to quality extends beyond just the initial product. We continuously strive to understand and control the factors that influence drug stability. If you are looking for a reliable source of Strontium Ranelate with comprehensive stability data and a deep understanding of its degradation profile, we are your ideal partner. Contact us to procure high-quality Strontium Ranelate and leverage our expertise in pharmaceutical analysis.